An agentic watcher. Regulation, market and partner changes, mapped to the step they affect.
Your shortlisted importer of record's legal entity identifier is near expiry.
An expired LEI stalls customs and KYC. Confirm renewal before you rely on them as MAH.
A CBIC draft notification for HS 3305 is circulating. Not yet enacted.
Landed-cost multiple rises 1.55x → ~1.63x. Re-test the breakeven price before committing inventory.
Local contribution €3.03 → €2.70 (-€0.33 / unit) if enacted. The test verdict holds at GO · conditional; the local scale-up margin narrows, so re-test breakeven before you commit inventory.
3 of 5 steps complete. Strategy and Partners are still open.
GO stays conditional until Partners diligence closes and the runway is funded.
Competitor shelf prices rose on 1mg and Nykaa; your price headroom widened.
Shelf headroom improves. An opportunity, not a blocker.
Negotiators signal a 2027 window; cosmetics are not yet confirmed in scope.
Could compress landed cost later. Monitor; do not plan around it yet.